Clinical Trial Update: Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on maintenance therapy with autologous cytokine-induced killer cells for nonsquamous non-small cell lung cancer, covering Phase 2 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Autologous cytokine-induced killer cells (cytokine-induced killer cells)

Snippet

Sponsor: People's Hospital of Guangxi Zhuang Autonomous Region | Conditions: Non-small Cell Lung Cancer | Phase 2, Phase 3 | Status: UNKNOWN